Literature DB >> 31368365

Circular RNA circVAPA Promotes Cell Proliferation in Hepatocellular Carcinoma.

Caifeng Liu1, Xingyang Zhong1, Jun Li1, Feng Xu1.   

Abstract

Hepatocellular carcinoma (HCC) is the most common malignancy in liver and is one of the leading causes of cancer-induced deaths all over the world. Circular RNAs (circRNAs) have been proven to be related to cancer initiation and progression in mounting reports. However, research on the role of circRNAs in human cancers, including HCC, is still in its infancy. circVAPA has been unmasked as oncogenic in colorectal cancer. Yet the function of circVAPA in HCC has never been elucidated. circVAPA, miR-377-3p, and prosaposin (PSAP) mRNA expression levels were detected by real-time quantitative PCR. PSAP protein levels were measured by Western blot. Cell proliferation was evaluated by CCK-8, colony formation, and EdU assays. Binding capacity was assessed by dual-luciferase reporter assay. circVAPA was upregulated in HCC cell lines and circVAPA depletion was associated with decreased HCC cell proliferation. circVAPA promotes PSAP expression through sequestering miR-377-3p. The suppression of HCC cell proliferation caused by circVAPA silence was revived by PSAP overexpression. This study revealed that circVAPA contributes to HCC cell proliferation through sponging miR-377-3p and thereby disinhibiting PSAP, shedding light on a new insight into HCC initiation and progression.

Entities:  

Keywords:  PSAP; circVAPA; hepatocellular carcinoma; miR-377-3p

Mesh:

Substances:

Year:  2019        PMID: 31368365     DOI: 10.1089/humc.2019.079

Source DB:  PubMed          Journal:  Hum Gene Ther Clin Dev        ISSN: 2324-8637            Impact factor:   5.032


  11 in total

1.  The Potential Tumor Promotional Role of circVAPA in Retinoblastoma via Regulating miR-615-3p and SMARCE1.

Authors:  Qibin Xu
Journal:  Onco Targets Ther       Date:  2020-08-05       Impact factor: 4.147

2.  circVAPA promotes the proliferation, migration and invasion of oral cancer cells through the miR-132/HOXA7 axis.

Authors:  Hao Chen; Ye Zhang; Kankui Wu; Xiaoyong Qiu
Journal:  J Int Med Res       Date:  2021-06       Impact factor: 1.671

3.  Circular RNA circVAPA knockdown suppresses colorectal cancer cell growth process by regulating miR-125a/CREB5 axis.

Authors:  Xiaoyu Zhang; Yingying Xu; Kenji Yamaguchi; Jinping Hu; Lianbo Zhang; Jianfeng Wang; Jifeng Tian; Wanying Chen
Journal:  Cancer Cell Int       Date:  2020-03-30       Impact factor: 5.722

4.  Circular RNA LARP4 correlates with decreased Enneking stage, better histological response, and prolonged survival profiles, and it elevates chemosensitivity to cisplatin and doxorubicin via sponging microRNA-424 in osteosarcoma.

Authors:  Yuhang Hu; Jiaao Gu; Hongtao Shen; Tuo Shao; Song Li; Wei Wang; Zhange Yu
Journal:  J Clin Lab Anal       Date:  2019-10-22       Impact factor: 2.352

5.  Circular RNA circVAPA promotes chemotherapy drug resistance in gastric cancer progression by regulating miR-125b-5p/STAT3 axis.

Authors:  Peng Deng; Ming Sun; Wen-Yan Zhao; Bin Hou; Kai Li; Tao Zhang; Feng Gu
Journal:  World J Gastroenterol       Date:  2021-02-14       Impact factor: 5.742

6.  CircPVT1 Regulates Cell Proliferation, Apoptosis and Glycolysis in Hepatocellular Carcinoma via miR-377/TRIM23 Axis.

Authors:  Nan Bu; Zheng Dong; Lingfeng Zhang; Weibo Zhu; Furong Wei; Sheng Zheng
Journal:  Cancer Manag Res       Date:  2020-12-16       Impact factor: 3.989

7.  Circular RNA circVAPA contributes to non-small-cell lung cancer progression via miR-342-3p-dependent regulation of ZEB2.

Authors:  Xiaoyang Liu; Yang Cheng; Yan Wang; Yinhong Zhang
Journal:  World J Surg Oncol       Date:  2021-11-29       Impact factor: 2.754

Review 8.  Circular RNAs regulate cancer-related signaling pathways and serve as potential diagnostic biomarkers for human cancers.

Authors:  Pranavi Garlapati; Jinjie Ling; Paul J Chiao; Jie Fu
Journal:  Cancer Cell Int       Date:  2021-06-23       Impact factor: 5.722

Review 9.  Circular RNAs in gastrointestinal cancer: Current knowledge, biomarkers and targeted therapy (Review).

Authors:  Xiaorui Zhao; Yue Wang; Qiongfang Yu; Pei Yu; Qiaoyu Zheng; Xue Yang; Dian Gao
Journal:  Int J Mol Med       Date:  2020-09-16       Impact factor: 4.101

10.  miR-378a-5p improved the prognosis and suppressed the progression of hepatocellular carcinoma by targeting the VEGF pathway.

Authors:  Haibo Zou; Lan Yang
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.